Please login to the form below

Not currently logged in

Dan Carucci becomes global chief medical officer of McCann Health

Carucci initially joined McCann in February 2018 as medical director

McCann Health has promoted Dan Carucci (pictured above) to the role of global chief medical officer, from his previous role as medical director.

Carucci joined McCann Health in February 2018, and has worked across nearly all aspects of the business during this time.

He is also a physician and molecular biologist with over 30 years of experience managing large and complex health programmes.

Previously, he was appointed as the first director of the Grand Challenges in Global Health Initiative, a programme for the Bill & Melinda Gates Foundation.

In addition, as vice president of global health at the United Nations Foundation, Carucci has also served on the board of the Global Fund to Fight AIDS, TB and Malaria.

He also chairs a scientific advisory group for the US National Institutes of Health (NIH) extramural programmes.

“Dan has deep global medical experience, a vast science research background and an incredibly impressive pedigree,” said John Cahill, global chief executive officer, McCann Health.

“It’s never been more important for our work to be grounded in science and for clients to trust that they have an agency partner on the team who not only understands their products but also has intimate knowledge of how they are used to benefit the global community,” he added.

“I look forward to working with our many dedicated and talented scientists, physicians and medical professionals, and with our strategy and creative teams to help guide our clients, public and private, to ensure the impact their work is meant to achieve,” said Carucci.

Article by
Lucy Parsons

24th February 2021

From: Marketing


Subscribe to our email news alerts

Featured jobs


Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...
Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...